Back to results
Not yet recruitingPhase 1

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

NCT06251544

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Houston Methodist Hospital

Houston, Texas, United States

Contact

Natalie Chen, MD

215-534-7895natalie.chen@bcm.edu
View on ClinicalTrials.gov
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer — TrialFind